Search results
Experts Predict Rise In COVID-19 Cases: Vaccine Stocks Climb - Moderna (NASDAQ:MRNA)
Benzinga· 2 days agoAccording to a report from NBC News, experts predict a small rise in COVID-19 cases as a newly...
Moderna and Pfizer In Talks With U.S. To Make a Bird Flu Vaccine
Barrons.com· 2 days agoOther vaccine stocks are climbing as well. Shares of CureVac which, like Moderna, develops messenger...
Vaccine Stocks Rise on Growing Threat of Bird Flu Infections
Zacks· 2 days agoFree Report) and Pfizer (PFE Quick QuotePFE - Free Report) to set up a possible vaccine program aimed at preventing the spread of the H5N1 virus, also known as bird flu, in ...
What to know about the new 'FLiRT' COVID variants
Fox News· 14 hours agoAccording to the World Health Organization, the "FLiRT" variants of the SARS-CoV-2 coronavirus have been the dominant forms of the virus circulating...
Novavax, Inc. (NASDAQ:NVAX) Given Average Recommendation of “Hold” by Brokerages
ETF DAILY NEWS· 5 days agoNovavax, Inc. (NASDAQ:NVAX – Get Free Report) has been given an average recommendation of “Hold” by the five analysts that are presently covering the firm, Marketbeat.com ...
Heard on the Street: Moderna Got a Boost From Bird Flu, but Don’t Count Your Chicks
The Wall Street Journal· 1 day agoModerna, BioNTech, CureVac and Novavax have added billions of dollars in combined market...
Free COVID-19 vaccines could be a thing of the past as federal program is set to expire early
Chicago Sun-Times· 2 days agoWhen COVID-19 vaccines entered the commercial market, the federal government introduced a program to...
Bird Flu Cases Spur Retail Trader Rush Into Vaccine Stocks
Bloomberg via Yahoo Finance· 2 days ago(Bloomberg) -- Mounting cases of bird flu in humans is luring the day trading crowd to snap up stock...
Moderna, CureVac, other vaccine stocks jump as new human bird-flu cases reported in U.S., Australia
Market Watch· 2 days agoVaccine-related stocks moved sharply higher Wednesday as new human bird-flu cases were reported in...
Pfizer plans to cut costs by $1.5 billion as demand for COVID vaccine dwindles
Quartz· 2 days agoPharma giant Pfizer announced Wednesday another cost-cutting initiative as the company struggles...